UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Medical Rehabilitation: Guidelines to Advance the Field With High-Impact Clinical Trials

Archives of physical medicine and rehabilitation, 2018-12, Vol.99 (12), p.2637-2648

2018

Volltextzugriff (PDF)

Clinical and patient-reported outcomes of fully adaptive MR-guided stereotactic radiotherapy to prostate: Real-world experience from the UK

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.303-303

2024

Volltextzugriff (PDF)

Edgardo Pesante: re-construcciones del intelectual santafesino

El hilo de la fábula, 2018-11 (18), p.253-264

2018

Volltextzugriff (PDF)

The Landscape of Stereotactic Ablative Radiotherapy

Cancers, 2024-08, Vol.16 (15)

2024

Volltextzugriff (PDF)

In Regard to Parry et al

International journal of radiation oncology, biology, physics, 2021-07, Vol.110 (3), p.912-913

2021

Volltextzugriff (PDF)

The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC)

Cancers, 2024-07, Vol.16 (15), p.2678

2024

Volltextzugriff (PDF)

Predicting benefit of radium 223 based on biochemical response and site of metastasis: A real life multicenter UK study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e17034-e17034

2021

Volltextzugriff (PDF)

Phase II trial of pembrolizumab for patients suffering from metastatic castration resistant prostate cancer (mCRPC) with DNA repair defects, high tumour mutation burden, and/or high CD3 counts (PERSEUS1)

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.138-138

2024

Volltextzugriff (PDF)

Robot‐assisted salvage seminal vesicle excision for isolated recurrence after low‐dose‐rate prostate brachytherapy

BJU international, 2022-06, Vol.129 (6), p.731-736

2022

Volltextzugriff (PDF)

Long‐term survival after low‐dose‐rate brachytherapy for prostate cancer: the Royal Surrey experience

BJU international, 2022-06, Vol.129 (6), p.723-730

2022

Volltextzugriff (PDF)

Net survival of men with localized prostate cancer after LDR brachytherapy

Brachytherapy, 2024-05, Vol.23 (3), p.329-334

2024

Volltextzugriff (PDF)

Hemi‐ablative low‐dose‐rate prostate brachytherapy for unilateral localised prostate cancer

BJU international, 2020-03, Vol.125 (3), p.383-390

2020

Volltextzugriff (PDF)

Stereotactic Magnetic Resonance–Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes

Advances in radiation oncology, 2024-09, Vol.9 (9), p.101574, Article 101574

2024

Volltextzugriff (PDF)

Is hemi-gland focal LDR brachytherapy as effective as whole-gland treatment for unilateral prostate cancer?

Brachytherapy, 2022-11, Vol.21 (6), p.870-876

2022

Volltextzugriff (PDF)

Long‐term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low‐dose‐rate brachytherapy for localised prostate cancer

BJU international, 2018-01, Vol.121 (1), p.38-45

2018

Volltextzugriff (PDF)

Long-term oncological outcomes and toxicity in 597 men aged < or =60ￂ years at time of low-dose-rate brachytherapy for localised prostate cancer

BJU international, 2018-01, Vol.121 (1), p.38

2018

Volltextzugriff (PDF)

Low‐dose‐rate brachytherapy for the treatment of localised prostate cancer in men with a high risk of disease relapse

BJU international, 2018-10, Vol.122 (4), p.610-617

2018

Volltextzugriff (PDF)

Low‐Dose‐Rate Prostate Brachytherapy (LDR‐PB) adopts postsurgical PSA value for definition of cure

BJUI compass, 2021-01, Vol.2 (1), p.9-10

2021

Volltextzugriff (PDF)

Salvage Radiotherapy

Salvage Therapy for Prostate Cancer, 2020, p.115-120

2020

Volltextzugriff (PDF)

Clinical Staging/Diagnostic Imaging in Salvage Therapy for Prostate Cancer

Salvage Therapy for Prostate Cancer, 2020, p.75-78

2020

Volltextzugriff (PDF)

Disease Recurrence after Radical Prostatectomy

Salvage Therapy for Prostate Cancer, 2020, p.47-50

2020

Volltextzugriff (PDF)

The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review)

Oncology reports, 2016-02, Vol.35 (2), p.614-624

2016

Volltextzugriff (PDF)

Dose–volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation

Radiotherapy and oncology, 2016-01, Vol.118 (1), p.79-84

2016

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(73)
Buchkapitel
(7)

Sprache

Englisch
(79)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Medical Rehabilitation: Guidelines to Advance the Field With High-Impact Clinical Trials

Clinical and patient-reported outcomes of fully adaptive MR-guided stereotactic radiotherapy to prostate: Real-world experience from the UK

Edgardo Pesante: re-construcciones del intelectual santafesino

The Landscape of Stereotactic Ablative Radiotherapy

In Regard to Parry et al

The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC)

Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial

Predicting benefit of radium 223 based on biochemical response and site of metastasis: A real life multicenter UK study

Phase II trial of pembrolizumab for patients suffering from metastatic castration resistant prostate cancer (mCRPC) with DNA repair defects, high tumour mutation burden, and/or high CD3 counts (PERSEUS1)

Robot‐assisted salvage seminal vesicle excision for isolated recurrence after low‐dose‐rate prostate brachytherapy

Long‐term survival after low‐dose‐rate brachytherapy for prostate cancer: the Royal Surrey experience

Net survival of men with localized prostate cancer after LDR brachytherapy

Hemi‐ablative low‐dose‐rate prostate brachytherapy for unilateral localised prostate cancer

Stereotactic Magnetic Resonance–Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes

Is hemi-gland focal LDR brachytherapy as effective as whole-gland treatment for unilateral prostate cancer?

Long‐term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low‐dose‐rate brachytherapy for localised prostate cancer

Long-term oncological outcomes and toxicity in 597 men aged < or =60ￂ years at time of low-dose-rate brachytherapy for localised prostate cancer

Low‐dose‐rate brachytherapy for the treatment of localised prostate cancer in men with a high risk of disease relapse

Low‐Dose‐Rate Prostate Brachytherapy (LDR‐PB) adopts postsurgical PSA value for definition of cure

Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes

Salvage Radiotherapy

Clinical Staging/Diagnostic Imaging in Salvage Therapy for Prostate Cancer

Disease Recurrence after Radical Prostatectomy

The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review)

Dose–volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation

Suchergebnisse filtern